- $1.76bn
- $2.70bn
- $1.11bn
- 76
- 74
- 36
- 65
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.12 | 24.6 | 220 | 756 | 1,111 |
Cost of Revenue | |||||
Gross Profit | 4.74 | 17.1 | 195 | 686 | 966 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.7 | 130 | 118 | 333 | 704 |
Operating Profit | -11.6 | -106 | 102 | 423 | 407 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.6 | -106 | 72.5 | 312 | 282 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.6 | -101 | 55.6 | 237 | 216 |
Net Income Before Extraordinary Items | |||||
Net Income | -11.6 | -101 | 55.6 | 237 | 216 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -11.6 | -101 | 55.6 | 214 | 194 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.227 | -0.565 | 0.586 | 1.93 | 1.75 |
Dividends per Share | |||||
Special Dividends per Share |